Welcome to the EXPAREL® (bupivacaine liposome injectable suspension) Information Resource Center!

A website intended for formulary committee members, administrators, or healthcare providers to gather information related to EXPAREL to assist the formulary committee or similar entity in carrying out its responsibilities for the selection of drugs for managed care or other similar organizations. This information is not intended for patients, caregivers, nonqualified healthcare professionals, or for promotional or commercial use.

EXPAREL is indicated for administration into the surgical site to produce postsurgical analgesia. Since its approval in 2011, EXPAREL has been used in more than 2 million patients. Use of EXPAREL has been evaluated, reviewed, and discussed in approximately 400 journal articles, conference presentations, and abstracts. Outcomes have been assessed in a broad range of both orthopedic and soft tissue surgical models.

If you are a member of formulary committee, a qualified healthcare professional, and/or administrator, click here to get started.

If you are not a healthcare professional or would like more product information, please visitdrabble.